10 Hep C Stocks on Wall Street's Watch List

Description:

According to Adam Feuerstein, "The end of the year will be a busy time for Hep C drug developers. Investors will be paying close attention to the third-quarter results from Vertex, watching to see if Incivek can maintain the scorching-fast start to its commercial launch." Read more here.

>>Also: 8 Biotech Stocks to Watch

>>Also: 5 Stocks Under $10 Setting Up to Trade Higher

Most Viewed Portfolios

View All

Articles

3 Tech Stocks Under $10 Triggering Breakout Trades

09.19.14 | 08:21 AM

DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percen...

Dividend Preview: 5 Dividend Stocks Ready to Pay You More

09.19.14 | 09:07 AM

BALTIMORE (Stockpickr) -- Don't get fooled by the flash of new all-time highs in the big stock indices; if you're not buying dividend names, you're...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter